Showing results (201-210 of 237) with videos related to

Sort By:
Pageof 24
ESC Heart Failure|June 25, 2020
Rationale and design of the EMPYREAN studyHirohiko Motoki, Izuru Masuda, Shinji Yasuno, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 24, 2019
Rate of Reoperation Decreased Significantly After Year 2002 in Patients With Crohn's DiseaseTakahide Shinagawa, Keisuke Hata, Hiroki Ikeuchi, et al.
Gastrointestinal Endoscopy|May 5, 2015
Effect of a stylet on a histological specimen in EUS-guided fine-needle tissue acquisition by using 22-gauge needles: a multicenter, prospective, randomized, controlled trialYoko Abe, Hiroshi Kawakami, Koji Oba, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|December 16, 2014
Efficacy of molecular response at 1 or 3 months after the initiation of dasatinib treatment can predict an improved response to dasatinib in imatinib-resistant or imatinib-intolerant Japanese patients with chronic myelogenous leukemia during the chronic phaseKoiti Inokuchi, Takashi Kumagai, Eri Matsuki, et al.
International Journal of Clinical Oncology|April 28, 2025
A multicenter randomized open-label phase 2 study investigating optimal antiemetic therapy for patients with advanced/recurrent gastric cancer treated with trastuzumab deruxtecan: the EN-hance studyToru Aoyama, Akira Ooki, Koji Oba, et al.
Annals of Surgical Oncology|September 18, 2016
The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal CancerMasato Kataoka, Mitsuro Kanda, Kiyoshi Ishigure, et al.
International Journal of Hematology|December 4, 2013
Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemiaTakashi Kumagai, Eri Matsuki, Koiti Inokuchi, et al.
Transplantation Proceedings|June 18, 2026
A Nomogram Predicts the Need for Internal Iliac Vein Dissection During Renal Transplantation: A Multicenter Collaborative StudyDaisuke Yamada, Yuki Nakamura, Yasuo Ishii, et al.
Cancer Chemotherapy and Pharmacology|September 25, 2019
JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancerTakayuki Yoshino, Masahito Kotaka, Katsunori Shinozaki, et al.
European Journal of Haematology|February 24, 2015
A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia-chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteriaKazunori Murai, Tomoaki Akagi, Kenji Shimosegawa, et al.
Pageof 24